Royce & Associates LP Invests $814,000 in Paysign, Inc. (NASDAQ:PAYS)

Royce & Associates LP bought a new position in Paysign, Inc. (NASDAQ:PAYS - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 221,711 shares of the company's stock, valued at approximately $814,000. Royce & Associates LP owned 0.42% of Paysign at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of PAYS. Renaissance Technologies LLC raised its stake in shares of Paysign by 25.0% in the second quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company's stock valued at $6,484,000 after purchasing an additional 301,000 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Paysign by 25.1% in the second quarter. Rhumbline Advisers now owns 35,835 shares of the company's stock valued at $154,000 after purchasing an additional 7,190 shares in the last quarter. Joule Financial LLC bought a new stake in Paysign in the third quarter valued at $1,478,000. Vanguard Group Inc. grew its position in Paysign by 3.0% in the first quarter. Vanguard Group Inc. now owns 1,649,043 shares of the company's stock valued at $6,035,000 after acquiring an additional 48,489 shares during the period. Finally, Algert Global LLC bought a new stake in Paysign in the second quarter valued at $46,000. Institutional investors and hedge funds own 25.89% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Barrington Research reiterated an "outperform" rating and issued a $7.00 price target on shares of Paysign in a research report on Monday, November 4th.

Paysign Price Performance

Shares of PAYS stock traded up $0.04 during trading hours on Thursday, hitting $3.43. 125,437 shares of the company's stock were exchanged, compared to its average volume of 250,042. The stock's 50-day moving average is $3.85 and its 200-day moving average is $4.29. The stock has a market cap of $183.68 million, a price-to-earnings ratio of 22.60 and a beta of 0.95. Paysign, Inc. has a 52 week low of $2.22 and a 52 week high of $5.59.

Paysign (NASDAQ:PAYS - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of $0.01 by $0.02. The company had revenue of $15.26 million for the quarter, compared to analysts' expectations of $14.96 million. Paysign had a return on equity of 30.64% and a net margin of 14.28%. During the same quarter in the prior year, the business earned $0.02 earnings per share. Equities research analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Insider Activity at Paysign

In other Paysign news, CEO Mark Newcomer sold 25,000 shares of the stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $3.27, for a total value of $81,750.00. Following the transaction, the chief executive officer now owns 9,236,886 shares of the company's stock, valued at approximately $30,204,617.22. This represents a 0.27 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Daniel Spence sold 100,000 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $3.60, for a total value of $360,000.00. Following the completion of the transaction, the insider now directly owns 9,090,000 shares in the company, valued at $32,724,000. The trade was a 1.09 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 301,360 shares of company stock worth $1,112,036 over the last 90 days. Insiders own 23.40% of the company's stock.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.